{
  "trial_id": "NCT03790137",
  "overall_assessment": "likely_ineligible",
  "inclusion": [
    {
      "criterion": "Subject is male or non-pregnant, non-lactating female, age 4 to 25 years, inclusive as of the day of the screening visit.",
      "label": "met"
    },
    {
      "criterion": "Female subjects of childbearing potential must have a negative serum pregnancy test at screening.",
      "label": "unknown"
    },
    {
      "criterion": "Subjects of childbearing or child-fathering potential must be willing to use medically acceptable forms of birth control, which includes abstinence, while in this study and for 90 days after the last dose of study drug.",
      "label": "met"
    },
    {
      "criterion": "Subject has a diagnosis of Sunflower Syndrome, where seizures are not completely controlled by their current treatment plan.",
      "label": "unknown"
    },
    {
      "criterion": "Subject experiences seizures including absence seizures and/or generalized tonic-clonic seizures which involve seeking out a light source, staring at the light source, and waving one hand in front of their eye(s).",
      "label": "met"
    },
    {
      "criterion": "Evidence of EEG in the medical history that shows generalized spike and wave discharges between seizures and a strong photoparoxysmal response during photic stimulation.",
      "label": "unknown"
    },
    {
      "criterion": "All medications or interventions for epilepsy must be stable for at least 4 weeks prior to screening and are expected to remain stable until Month 3.",
      "label": "met"
    },
    {
      "criterion": "Subject and/or parent/guardian has been informed of the nature of the study and informed consent has been obtained from the subject and/or legally responsible parent/guardian.",
      "label": "unknown"
    },
    {
      "criterion": "Subject has provided assent in accordance with Institutional Review Board (IRB)/Ethics Committee requirements, if capable.",
      "label": "unknown"
    },
    {
      "criterion": "Subjects parent/caregiver is willing and able to be compliant with diary completion, visit schedule, and study drug accountability.",
      "label": "met"
    }
  ],
  "exclusion": [
    {
      "criterion": "Subject has a known hypersensitivity to fenfluramine hydrochloride or any other ingredients in the investigational drug.",
      "label": "unknown"
    },
    {
      "criterion": "Subject's etiology of seizures is a degenerative neurological disease.",
      "label": "met"
    },
    {
      "criterion": "Subject is pregnant.",
      "label": "met"
    },
    {
      "criterion": "Subject is not willing to comply with a method of birth control acceptable to the PI during the study and for 90 days following completion of the study.",
      "label": "met"
    },
    {
      "criterion": "Subject is breastfeeding.",
      "label": "met"
    },
    {
      "criterion": "Subject has a history of drug or alcohol abuse.",
      "label": "unknown"
    },
    {
      "criterion": "Subject has pulmonary arterial hypertension.",
      "label": "unknown"
    },
    {
      "criterion": "Subject has current or past history of cardiovascular or cerebrovascular disease, such as cardiac valvulopathy, myocardial infarction or stroke, or clinically significant structural cardiac abnormality.",
      "label": "met"
    }
  ],
  "notes": "Patient has a history of severe intellectual disability, CHF, epilepsy. He has been experiencing seizures and has not been able to control them with his current treatment plan.",
  "_meta": {
    "topic_id": "9",
    "trial_id": "NCT03790137",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}